SHS has sold Spiegelberg to Luciole Medical AG

SHS and a minority co-shareholder have sold Spiegelberg GmbH to Luciole Medical AG.

Spiegelberg is a manufacturer of neuromonitoring and neurosurgical medical products. The company is known for its unique self-calibrating intra-cranial pressure monitors and its solid probes. The portfolio further includes disposables such as cerebrospinal fluid management catheters. The company was established more than 30 years ago in Hamburg, Germany, and is active in more than 40 countries.

Luciole Medical has established a first-mover position in brain monitoring by providing a complete solution to measure brain function parameters in a broad range of hospital settings, from surgeries and anesthesia to neurocritical care. Luciole Medical’s adhesive patch, intracranial probe and end-to-end analytics platform that can integrate information from additional sources, provide an array of tools to achieve unparalleled real-time data capture of cerebral oxygenation, an important predictor of brain function. It is the only company with a patch and a patented technology that can also measure the blood flow in the brain.

Since its foundation in 1993, SHS has been investing in innovative companies in the healthcare sector. With its investments, the firm helps shape European champions in their respective healthcare segments or support them in their further expansion. In addition to capital, SHS essentially supports its networks and expertise in the areas of approval and reimbursement in the USA and China, marketing and sales, staffing and exit planning.

Oaklins’ team in Germany acted as the exclusive sell-side M&A advisor in this transaction.